Key takeaways
Simbrinza (brinzolamide/brimonidine) and dorzolamide are both used to lower pressure in the eye caused by open-angle glaucoma or ocular hypertension (high eye pressure). But they have several differences. Simbrinza is a combination of two medications: brinzolamide, a carbonic anhydrase inhibitor, and brimonidine, an alpha-2 agonist. Dorzolamide, on the other hand, is a single medication that is also a carbonic anhydrase inhibitor. Simbrinza is only available as a brand medication, making it potentially more expensive, while dorzolamide is available in a lower cost generic form. Both medications are used 3 times a day and can cause similar side effects like eye irritation. However, Simbrinza combines two medications into one drop, which can be more convenient than using multiple separate drops.
